1 Min Read
Nov 3 (Reuters) - Corline Biomedical AB :
* Applies for Orphan Drug status for Renaparin at U.S. Food and Drug Administration (FDA) Source text for Eikon:
Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.